Empagliflozin vs. DPP-4 inhibitors and GLP-1 Receptor Agonists Cost of Care Study: a German claims data analysis

First published 25/10/2019

Last updated 16/10/2026

EU PAS number:

EUPAS31950

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

1245-0221_CTP_final-rule_Redacted.pdf

English (1.11 MB - PDF) View document

Study results

No information provided.

Study report

Abstract of study report

1245-0221_Synopsis.pdf

English (215.78 KB - PDF) View document

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Empagliflozin vs. DPP-4 inhibitors and GLP-1 Receptor Agonists Cost of Care Study: a German claims data analysis

Secondary tabs

Share this page